Europe Subcutaneous Drug Delivery Devices Market Size & Outlook
Europe subcutaneous drug delivery devices market, 2018-2030 (US$M)
Related Markets
Europe subcutaneous drug delivery devices market highlights
- The Europe subcutaneous drug delivery devices market generated a revenue of USD 7,619.8 million in 2023.
- The market is expected to grow at a CAGR of 10.7% from 2024 to 2030.
- In terms of segment, pen injectors was the largest revenue generating product in 2023.
- Wearable injectors is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 7,619.8 million |
| Market revenue in 2030 | USD 15,570.4 million |
| Growth rate | 10.7% (CAGR from 2023 to 2030) |
| Largest segment | Pen injectors |
| Fastest growing segment | Wearable injectors |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors, Needle-free injectors |
| Key market players worldwide | Gerresheimer AG ADR, Medtronic PLC, Ypsomed Holding AG, Novo Nordisk A/S ADR, Insulet Corp, Becton Dickinson & Co, West Pharmaceutical Services Inc, PHARMAJET, Unilife Corporation |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.5% of the global subcutaneous drug delivery devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 13,711.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Subcutaneous Drug Delivery Devices Market Scope
Subcutaneous Drug Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe subcutaneous drug delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to subcutaneous drug delivery devices market will help companies and investors design strategic landscapes.
Pen injectors was the largest segment with a revenue share of 36.86% in 2023. Horizon Databook has segmented the Europe subcutaneous drug delivery devices market based on prefilled syringes, pen injectors, auto-injectors, wearable injectors, needle-free injectors covering the revenue growth of each sub-segment from 2018 to 2030.
Europe held the second-largest revenue share of the global subcutaneous drug delivery devices market in 2023. The UK, France, Germany, Italy, and Spain are the major markets in this region. Growth in the region can be attributed to the increasing prevalence of chronic diseases, such as diabetes, which require regular medication.
According to the International Diabetes Federation, around 56.6 million adults in Europe were living with diabetes in 2022, and this number is expected to surge in the coming decade, highlighting the growing patient population.
Reasons to subscribe to Europe subcutaneous drug delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe subcutaneous drug delivery devices market databook
-
Our clientele includes a mix of subcutaneous drug delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe subcutaneous drug delivery devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe subcutaneous drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe subcutaneous drug delivery devices market size, by country, 2018-2030 (US$M)
Europe Subcutaneous Drug Delivery Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
